Amprius Technologies (NYSE:AMPX) Earns Buy Rating from Needham & Company LLC

Key Points

• Analyst sentiment is bullish: Needham reaffirmed a Buy with a $20 price target (about 12.9% upside), and the sell‑side consensus is a "Moderate Buy" with an average target of $19.75 (eight Buys, one Sell).
• Operational progress but still unprofitable: Amprius reported record revenue and its first quarter of positive adjusted EBITDA with new commercial wins (including Nokia), yet it still posts negative net margin/ROE and FY2026 guidance of -0.060 EPS.
• Ownership and volatility risks: Insiders sold roughly 2.39 million shares (~$26.4M) in the past 90 days and institutional ownership is light (~5%), which could amplify price swings despite recent upgrades.

Amprius Technologies (NYSE:AMPX - Get Free Report)'s stock had its "buy" rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They currently have a $20.00 price target on the stock. Needham & Company LLC's target price would indicate a potential upside of 12.90% from the company's previous close.

Other equities analysts have also issued reports about the stock. Oppenheimer reissued an "outperform" rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. B. Riley Financial upped their price target on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a "buy" rating in a research report on Monday. Cantor Fitzgerald raised their price objective on Amprius Technologies from $16.00 to $20.00 and gave the stock an "overweight" rating in a research report on Friday. Craig Hallum boosted their price objective on Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research note on Friday. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $19.75.

Amprius Technologies Stock Performance

Shares of AMPX stock opened at $17.72 on Tuesday. The firm's 50-day moving average is $11.07 and its 200-day moving average is $10.82. The stock has a market cap of $2.31 billion, a price-to-earnings ratio of -52.10 and a beta of 3.04. Amprius Technologies has a 52-week low of $1.70 and a 52-week high of $17.74.

Amprius Technologies (NYSE:AMPX - Get Free Report) last released its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The firm had revenue of $25.23 million during the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Sell-side analysts predict that Amprius Technologies will post -0.45 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the completion of the sale, the chief technology officer owned 748,696 shares of the company's stock, valued at approximately $9,014,299.84. This trade represents a 39.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kang Sun sold 950,548 shares of the firm's stock in a transaction on Friday, January 16th. The shares were sold at an average price of $11.07, for a total transaction of $10,522,566.36. Following the sale, the director owned 1,403,651 shares in the company, valued at approximately $15,538,416.57. This trade represents a 40.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 2,392,269 shares of company stock valued at $26,384,359 over the last 90 days. 12.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in AMPX. EWA LLC grew its stake in shares of Amprius Technologies by 3.8% in the fourth quarter. EWA LLC now owns 19,958 shares of the company's stock worth $157,000 after acquiring an additional 723 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Amprius Technologies by 14.7% in the 3rd quarter. Victory Capital Management Inc. now owns 11,817 shares of the company's stock worth $124,000 after buying an additional 1,516 shares during the last quarter. Graham Capital Management L.P. boosted its position in Amprius Technologies by 3.2% in the fourth quarter. Graham Capital Management L.P. now owns 49,596 shares of the company's stock worth $391,000 after purchasing an additional 1,551 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Amprius Technologies by 5.1% in the fourth quarter. The Manufacturers Life Insurance Company now owns 33,280 shares of the company's stock worth $263,000 after buying an additional 1,621 shares during the last quarter. Finally, First Trust Advisors LP grew its position in shares of Amprius Technologies by 6.7% during the 4th quarter. First Trust Advisors LP now owns 32,744 shares of the company's stock valued at $258,000 after acquiring an additional 2,066 shares during the period. Hedge funds and other institutional investors own 5.04% of the company's stock.

Amprius Technologies News Roundup

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities substantially lifted its forward earnings outlook, forecasting profitable quarters in 2026–2027 and a FY2027 EPS of $0.18, signaling a model shift from loss to profitability that supports higher valuation expectations.
• Positive Sentiment: B. Riley raised its price target from $16 to $22 and keeps a Buy rating — a material upward target revision that likely contributed to buying interest. B. Riley raises price target to $22
• Positive Sentiment: Recent analyst coverage (including price-target lifts into the low $20s and a fair-value uptick) cites record revenue, triple‑digit y/y growth and the company’s first quarter of positive adjusted EBITDA — fundamental improvements that justify renewed investor interest. How The Amprius Investment Story Is Shifting
• Positive Sentiment: Operational wins: management reported broad adoption of 2nd‑generation silicon‑anode batteries, a new commercial win with Nokia Drone Networks, and faster-than-expected progress toward NDAA compliance — each improving revenue visibility and defense/government addressable market access. Revenue milestone and EBITDA turn
• Positive Sentiment: Technical and market‑structure tailwinds: analysts and MarketBeat note record trading volume and technical convergence (daily/weekly/monthly), which can validate price moves and attract momentum traders. MarketBeat volume/technical note
• Positive Sentiment: Additional analyst support: Roth MKM reiterated a Buy and other outlets have raised targets (e.g., $21), reinforcing positive sentiment from the sell side. Roth MKM buy reiteration Price target raised to $21
• Neutral Sentiment: Market structure caveat — institutional ownership remains light (~5%) even as recent flows show net accumulation; increased coverage is positive but the shareholder base is still developing, which can amplify both up- and downside moves. MarketBeat on institutional trends
• Negative Sentiment: Risks remain: the consensus for the current fiscal year is still negative (about -$0.45 EPS), the company reported negative net margin and negative ROE recently, and FY2026 guidance implies continued near-term losses — factors that could limit sustainable upside until profitability is consistent.
• Negative Sentiment: Valuation and volatility risk — AMPX trades near its 12‑month high with a high beta; if growth expectations disappoint (contract timing, NDAA delays, or production hiccups), the stock could reverse quickly.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.